Check out the latest news from Cinclus Pharma
It all started with a summer job at Astra Zeneca. Today, Kjell is one of Sweden's most experienced drug developers in acid secretion inhibition and has played an important role in developing globally successful drugs for reflux disease.
Read more
Christer Ahlberg participated in Aktiespararnas event Stora Aktiedagen in Gothenburg on November 7th. He presented Cinclus Pharma and the positive topline data released for our Phase II eGERD study LEED last week.
Read more
On September 1st, we had LPO – Last Patient Out, from the Phase II study of linaprazan glurate. The study includes a total of 228 patients.
Read more